Condition
Botulinum Toxin Injection
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Not Yet Recruiting1
Unknown1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07707791Not ApplicableNot Yet Recruiting
Pretibial TENS for Pain and Anxiety During Intravesical OnabotulinumtoxinA Injection
NCT07108920RecruitingPrimary
Analysis of Balance Disorders After Botulinum Toxin Treatment in the Rectus Femoris in Patients With a Stiff Knee Gait
NCT04283916Unknown
Botulinum Toxin Injection in the Treatment of Open Abdomen
Showing all 3 trials